ALFA Finder| Management target | Revenue 2030 |
|---|
| Revenue growth | 12.7% YoY consolidated |
|---|---|
| Margins | EBITDA margin expanded 256 bps YoY to 21.5%. |
| Demand visibility | Sustained demand across specialties; IP volumes up 11.4%. |
| Management confidence | High, citing strong earnings momentum and expansion roadmap. |
Growth
Consolidated EBITDA grew 27.9% YoY; standalone revenue increased 12.9%. Gurgaon facility saw 11.4% IP volume growth and 7.4% ARPOB increase.
Outlook
Expanding bed capacity to ~2,000 by 2030. New 300+ bed Raipur hospital operational; 650+ bed South Delhi hospital expected Q4 FY29.
Risks
Other income declined due to utilization of IFC funds for expansion; reliance on high occupancy rates (currently 65.7%).
Last quarter's promises, checked
Delivered
- Raipur facility Q1 FY27 launch → Operational July 2026 (= BEAT)
- Gurgaon EBITDA margin >20% → delivered 21.5% (= BEAT)
- International patient revenue 27-30% → delivered 27-30% (= BEAT)
Partly delivered
- Gurgaon occupancy target 70% → delivered 65.7% (= PARTIAL)
Investor Presentation filed with BSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹313.50
- Market cap
- ₹4,963 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 43.3×Sector 54.5×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong growth led by Gurgaon's record EBITDA and new Raipur operations. Aggressive expansion plans aim for 2,000 beds within five years despite regulatory drug pricing concerns.
Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.1 Cr · +3.7% YoY
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.